Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2017
Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments
Katja Pinker, Christopher Riedl, Wolfgang A Weber
Clinical Nuclear Medicine
|
March 15, 2018
Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT
John Ward, Ariela Noy, Gary Ulaner, et al.
Clinical Nuclear Medicine
|
June 5, 2018
Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer
Sonia Mahajan, Reema Goel, Christopher Riedl, et al.
Abdominal Imaging
|
February 26, 2008
Renal oncocytosis: imaging considerations
Nikki Ariaratnam, Christopher Riedl, Satish Tickoo, et al.
Clinical and Translational Imaging
|
December 7, 2020
PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?
Ali Pirasteh, Christopher Riedl, Marius Erik Mayerhoefer, et al.
Wiener Klinische Wochenschrift
|
May 31, 2012
[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families]
Christian F Singer, Muy-Kheng Tea, Gunda Pristauz, et al.
Nature Biomedical Engineering
|
April 12, 2022
Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location
Edwin C Pratt, Magdalena Skubal, Benedict Mc Larney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Human Gene Therapy
|
August 30, 2008
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma
Kaitlyn J Kelly, Yanghee Woo, Peter Brader, et al.
Surgery
|
December 8, 2007
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus
Shu-Fu Lin, Zhenkun Yu, Christopher Riedl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2017
Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments
Katja Pinker, Christopher Riedl, Wolfgang A Weber
Clinical Nuclear Medicine
|
March 15, 2018
Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT
John Ward, Ariela Noy, Gary Ulaner, et al.
Clinical Nuclear Medicine
|
June 5, 2018
Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer
Sonia Mahajan, Reema Goel, Christopher Riedl, et al.
Abdominal Imaging
|
February 26, 2008
Renal oncocytosis: imaging considerations
Nikki Ariaratnam, Christopher Riedl, Satish Tickoo, et al.
Clinical and Translational Imaging
|
December 7, 2020
PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?
Ali Pirasteh, Christopher Riedl, Marius Erik Mayerhoefer, et al.
Wiener Klinische Wochenschrift
|
May 31, 2012
[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families]
Christian F Singer, Muy-Kheng Tea, Gunda Pristauz, et al.
Nature Biomedical Engineering
|
April 12, 2022
Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location
Edwin C Pratt, Magdalena Skubal, Benedict Mc Larney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Human Gene Therapy
|
August 30, 2008
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma
Kaitlyn J Kelly, Yanghee Woo, Peter Brader, et al.
Surgery
|
December 8, 2007
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus
Shu-Fu Lin, Zhenkun Yu, Christopher Riedl, et al.
Page
of 2